How would you manage metastatic small cell/neuroendocrine bladder cancer after response to 6 cycles of platinum/etoposide?  

If any clinical benefit (ie. CR, PR or SD) would you consider switch maintenance avelumab, surveillance until progression, or an alternate regimen?



Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at University of Washington School of Medicine
Excellent and thoughtful response by @Guru P. Sonp...
Sign in or Register to read more